238 related articles for article (PubMed ID: 24184776)
21. Bis(hetero)aryl derivatives as unique kinesin spindle protein inhibitors.
Matsuno K; Sawada J; Sugimoto M; Ogo N; Asai A
Bioorg Med Chem Lett; 2009 Feb; 19(4):1058-61. PubMed ID: 19167222
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of a kinesin inhibitor.
Sakowicz R; Finer JT; Beraud C; Crompton A; Lewis E; Fritsch A; Lee Y; Mak J; Moody R; Turincio R; Chabala JC; Gonzales P; Roth S; Weitman S; Wood KW
Cancer Res; 2004 May; 64(9):3276-80. PubMed ID: 15126370
[TBL] [Abstract][Full Text] [Related]
24. New Alkoxy Flavone Derivatives Targeting Caspases: Synthesis and Antitumor Activity Evaluation.
Moreira J; Ribeiro D; Silva PMA; Nazareth N; Monteiro M; Palmeira A; Saraiva L; Pinto M; Bousbaa H; Cidade H
Molecules; 2018 Dec; 24(1):. PubMed ID: 30602686
[TBL] [Abstract][Full Text] [Related]
25. Recent progress in the identification and clinical evaluation of inhibitors of the mitotic kinesin KSP.
Knight SD; Parrish CA
Curr Top Med Chem; 2008; 8(10):888-904. PubMed ID: 18673173
[TBL] [Abstract][Full Text] [Related]
26. CPUYJ039, a newly synthesized benzimidazole-based compound, is proved to be a novel inducer of apoptosis in HCT116 cells with potent KSP inhibitory activity.
Jiang C; Yang L; Wu WT; Guo QL; You QD
J Pharm Pharmacol; 2011 Nov; 63(11):1462-9. PubMed ID: 21988427
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
28. The synthesis and evaluation of flavone and isoflavone chimeras of novobiocin and derrubone.
Mays JR; Hill SA; Moyers JT; Blagg BS
Bioorg Med Chem; 2010 Jan; 18(1):249-66. PubMed ID: 19932969
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and evaluation of a novel prodrug, a S-trityl-
Fukai R; Ogo N; Ichida T; Yamane M; Sawada JI; Miyoshi N; Murakami H; Asai A
Eur J Med Chem; 2021 Apr; 215():113288. PubMed ID: 33640763
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.
Wang G; Wang F; Cao D; Liu Y; Zhang R; Ye H; Li X; He L; Yang Z; Ma L; Peng A; Xiang M; Wei Y; Chen L
Bioorg Med Chem Lett; 2014 Jul; 24(14):3158-63. PubMed ID: 24863745
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and evaluation of tetrahydroisoquinolines as new kinesin spindle protein inhibitors.
Jiang C; You Q; Liu F; Wu W; Guo Q; Chern J; Yang L; Chen M
Chem Pharm Bull (Tokyo); 2009 Jun; 57(6):567-71. PubMed ID: 19483335
[TBL] [Abstract][Full Text] [Related]
33. Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: synthesis and in vitro biological evaluation. Part 1.
Bozorov K; Ma HR; Zhao JY; Zhao HQ; Chen H; Bobakulov K; Xin XL; Elmuradov B; Shakhidoyatov K; Aisa HA
Eur J Med Chem; 2014 Sep; 84():739-45. PubMed ID: 25064350
[TBL] [Abstract][Full Text] [Related]
34. Developments of kinesin spindle protein inhibitors as antitumor agents based on the five-membered heterocycle scaffolds.
Zhao GD; Wan RZ; Liu ZP
Curr Med Chem; 2014; 21(23):2691-701. PubMed ID: 24606497
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring.
Chinthala Y; Kumar Domatti A; Sarfaraz A; Singh SP; Kumar Arigari N; Gupta N; Satya SK; Kotesh Kumar J; Khan F; Tiwari AK; Paramjit G
Eur J Med Chem; 2013; 70():308-14. PubMed ID: 24177357
[TBL] [Abstract][Full Text] [Related]
36. Discovery of allosteric inhibitors of kinesin spindle protein (KSP) for the treatment of taxane-refractory cancer: MK-0731 and analogs.
Cox CD; Garbaccio RM
Anticancer Agents Med Chem; 2010 Nov; 10(9):697-712. PubMed ID: 21235439
[TBL] [Abstract][Full Text] [Related]
37. Synthetic studies on mitotic kinesin Eg5 inhibitors: synthesis and structure-activity relationships of novel 2,4,5-substituted-1,3,4-thiadiazoline derivatives.
Yamamoto J; Amishiro N; Kato K; Ohta Y; Ino Y; Araki M; Tsujita T; Okamoto S; Takahashi T; Kusaka H; Akinaga S; Yamashita Y; Nakai R; Murakata C
Bioorg Med Chem Lett; 2014 Aug; 24(16):3961-3. PubMed ID: 25001485
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, anticancer screening, docking studies and in silico ADME prediction of some β-carboline derivatives.
Abdelsalam MA; AboulWafa OM; M Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N; Elaasser MM
Future Med Chem; 2018 May; 10(10):1159-1175. PubMed ID: 29787297
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents.
Yao RS; Lu XQ; Guan QX; Zheng L; Lu X; Ruan BF
Eur J Med Chem; 2013 Apr; 62():222-31. PubMed ID: 23353741
[TBL] [Abstract][Full Text] [Related]
40. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage.
Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB
Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
